SCHEMBL20032574

SCHEMBL20032574

CC(=O)[C@@H]1C[C@@H]1C(=O)c1ccc2c(c1)CCCO2

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CTNNB1 P35222 7/20 0.51
WNT3A P56704 7/20 0.51
PRKCI P41743 1/20 0.44
CACNA1H O95180 1/20 0.42
TAS1R3 Q7RTX0 2/20 0.40
TAS1R1 Q7RTX1 2/20 0.40
ACHE P22303 1/20 0.39
PIR O00625 1/20 0.39
HSF1 Q00613 1/20 0.39
FOXO1 Q12778 1/20 0.38
CLK1 P49759 1/20 0.38
DYRK1A Q13627 1/20 0.38
DYRK1B Q9Y463 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
KDM4E B2RXH2 1/20 0.38
KMO O15229 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16614190 0.88 CTNNB1 (0.55) CTNNB1WNT3APRKCICACNA1HTAS1R3
SCHEMBL1726294 0.80 CTNNB1 (0.61) CTNNB1WNT3APRKCITAS1R3TAS1R1
SCHEMBL15337102 0.80 KMO (0.52) CTNNB1WNT3APRKCITAS1R3TAS1R1
SCHEMBL7057339 0.76 CTNNB1 (0.56) CTNNB1WNT3APRKCITAS1R3TAS1R1
SCHEMBL20032579 0.75 CTNNB1 (0.52) CTNNB1WNT3ARAB9AKDM4EKMO
SCHEMBL875455 0.75 CTNNB1 (0.67) CTNNB1WNT3APRKCITAS1R3TAS1R1
SCHEMBL31262479 0.75 CTNNB1 (0.67) CTNNB1WNT3APRKCITAS1R3TAS1R1
SCHEMBL16599887 0.75 KMO (0.48) CTNNB1WNT3APRKCICACNA1HACHE
SCHEMBL16599885 0.75 KMO (0.48) CTNNB1WNT3APRKCICACNA1HACHE
SCHEMBL20032573 0.75 TDP1 (0.63) NPC1RAB9AKDM4EKMO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9938252-B2 Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof CHDI FOUNDATION, INC. (US) 2018-04-10 US disclosed